Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed2
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT02168179Not ApplicableWithdrawn
KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast Cancer
Ductal Breast Carcinoma in SituSkin Reactions Secondary to Radiation TherapyStage IA Breast Cancer+4 more
PrincipalinvestigatorStart date: 2014-12-01
NCT01561014Phase 1Completed
Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionAdenocarcinoma of the Stomach+5 more
PrincipalinvestigatorStart date: 2007-04-01
NCT01534637Phase 2Completed
Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer
Extrahepatic Bile Duct CancerNauseaStage II Pancreatic Cancer+3 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Joanne Mortimer

City of Hope Medical Center

Related
8 trials

Shared therapeutic areas:

Stage IA Breast CancerStage IB Breast CancerStage IIA Breast Cancer+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score7%

Vincent Chung

City of Hope Medical Center

Related
9 trials

Shared therapeutic areas:

Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionStage IV Pancreatic Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Agustin Garcia, MD

University of Southern California

Related
8 trials

Shared therapeutic areas:

Stage IA Breast CancerStage IB Breast CancerStage IIIA Breast Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Norman Wolmark, MD

NSABP Foundation Inc

Related
54 trials

Shared therapeutic areas:

Stage IB Breast CancerStage IIB Breast CancerStage IIIA Breast Cancer

Worked with same sponsors:

Merck Sharp & Dohme LLCNational Cancer Institute (NCI)
Similarity Score4%

Mireille Michel-Cherqui, MD

Hopital Foch

Related
8 trials

Shared therapeutic areas:

NauseaVomiting
Similarity Score3%

Roya Yumul, MD, PhD

Cedars-Sinai Medical Center

Related
9 trials

Shared therapeutic areas:

NauseaVomiting
Similarity Score3%

Mohamed S Abdelhafez, MD

Mansoura University

Related
10 trials

Shared therapeutic areas:

NauseaVomiting
Similarity Score3%

Jose CA Carvalho, MD

MOUNT SINAI HOSPITAL

Related
27 trials

Shared therapeutic areas:

NauseaVomiting
Similarity Score3%

Steven R. Alberts, MD

Mayo Clinic

Related
14 trials

Shared therapeutic areas:

Extrahepatic Bile Duct CancerAdenocarcinoma of the Gastroesophageal Junction

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Stage III Pancreatic CancerStage IV Pancreatic Cancer

Worked with same sponsors:

Merck Sharp & Dohme LLCNational Cancer Institute (NCI)
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT02168179Not ApplicablePrincipalInvestigator

KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast Cancer

Ductal Breast Carcinoma in SituSkin Reactions Secondary to Radiation TherapyStage IA Breast Cancer+4 more
Withdrawn
NCT01561014Phase 1PrincipalInvestigator

Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionAdenocarcinoma of the Stomach+5 more
Completed
NCT01534637Phase 2PrincipalInvestigator

Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer

Extrahepatic Bile Duct CancerNauseaStage II Pancreatic Cancer+3 more
Completed

All 3 trials loaded